SyntheticMR AB (”SyntheticMR”), a subsidiary of Accelerator Nordic AB (”Accelerator”), has appointed Staffan Persson as Chairman of the Board prior to the planned IPO and spin-off from Accelerator during the fall of 2013.
Staffan Persson has extensive experience of listed companies and is, apart from Chairman of the Board of Accelerator, also Chairman of DIBS Payment Services AB as well as Board Member of The Lexington Company AB, Cinnober Financial Technology AB, as well as several other public and private companies. Through the wholly-owned company Nortal Investments AB, and through his family, Staffan Persson is the largest shareholder of Accelerator with circa 33 percent of voting rights and capital and also owns circa 13 percent of voting rights and capital of SyntheticMR.
”SyntheticMR is focusing on establishing partnerships for an international launch of the software SyMRI and has potential for a very positive value growth”, says Staffan Persson.
The Board of Accelerator has previously announced that it has decided to prepare for a spin-off of the subsidiary SyntheticMR through distribution of Accelerator’s shares in SyntheticMR to the shareholders of Accelerator. The decision to spin-off SyntheticMR is to be taken at an Extraordinary General Meeting during the fall of 2013. After the spin-off from Accelerator, the Board of Accelerator has proposed that SyntheticMR is to be listed on the Aktietorget exchange in Stockholm, Sweden.
SyntheticMR has developed SyMRI™, software for MRI that provides improved efficiency and better decision support through shortening the scan time per patient and at the same time producing quantitative data. To date, the software is sold for clinical use in Europe. The plan is to launch SyMRI on a broader scale internationally through partnerships with global MRI system suppliers. During 2012, SyntheticMR signed and evaluation agreement with one of the market leading MRI system suppliers.
For additional information, please contact Staffan Persson, Chairman of the Board of Accelerator Nordic AB and SyntheticMR AB, +46 70 321 00 98, or Maria Wrethag, CEO of Accelerator Nordic
AB, +46 76 119 19 83.
Accelerator Nordic AB is a group of Life Science companies focused on Imaging Software and Medical Nanotechnology. Accelerator’s subsidiaries have exposure towards large growth markets such as medical imaging and orthopedics. Accelerator Nordic is publicly traded on the Aktietorget exchange in Stockholm, Sweden. For more information please visit, www.acceleratorab.se.